Impact Evaluation of the Digital Connect Project for Homebound Older Adults

January 8, 2024 updated by: Prof. Yu, Doris Sau Fung, The University of Hong Kong

Impact Evaluation of the Digital Connect Project for Homebound Older Adults: A Target Trial Emulation

The goal of this study is to evaluate the impact of the Digital Connect Project on increasing functional capacity defined by the WHO-ICOPE and health-related quality of life (HRQL) among homebound older adults.

Study Overview

Status

Recruiting

Conditions

Detailed Description

The Hong Kong Jockey Club Charities Trust is launching the Digital Connect project to increase the well-being and social connectedness of the homebound older adults. A total of 32 NGOs are applying for 7,500 tablets and data plan (in total) through this project. Different digital programs will be rolled out to enhance their well-being and social connectedness. This study aim is to capture the impact of this Digital Connect project on the health outcomes of the homebound older adults. The tablet intervention will be offered by the NGOs within a 2-year timeframe. Web-based multi-domain lifestyle training intervention will be conducted to promoted and focus three lifestyles: nutritional advice, exercise and cognitive training; chat communication with research team, and personalized agenda on daily activities and an information library.

The object of this study is to explore the dose-response relationship between online engagement in the different types of activity and the improvement in the corresponding health outcomes, including the five domains: (1) Physical function, (2) Cognitive function, (3) Psychological function, (4) Social function and (5) Health-related quality of life. One baseline assessment and four follow-ups will be arranged in every 3-month interval. To account for immortal time bias, each subject will be created with two clones at time zero and assigned each of the two clones to either treatment or control group, respectively.

The engagement experience will be explored by interviewing the participants and service stakeholders through the planning and delivery of the digital intervention for the homebound older adults.

Study Type

Interventional

Enrollment (Estimated)

1024

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Doris Sau Fung YU, PhD
  • Phone Number: 852 3917 6319
  • Email: dyu1@hku.hk

Study Locations

      • Hong Kong, Hong Kong
        • Recruiting
        • The University of Hong Kong
        • Contact:
          • Doris Sau Fung Yu, PhD
          • Phone Number: 3917 6319
          • Email: dyu1@hku.hk

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • age > 65
  • consent to participate
  • able to participate in the impact assessment as evidence by a test score of > 6 on the Abbreviated Mental Test
  • has the functional ability to engage in the digital intervention

Exclusion Criteria:

-

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Treatment status
To account for immortal time bias, each subject will be created with two clones at time zero and assigned each of the two clones to either treatment or no-treatment status, respectively. The treatment status in each evaluative endpoint (i.e., 3-month, 6-month, and 12-month) is defined as subjects who have received the digital intervention for the respective length of time since the time zero during which the intervention has just commenced.
Web-based multi-domain lifestyle training intervention will be conducted to promoted and focus three lifestyles: nutritional advice, exercise and cognitive training; chat communication with research team, and personalized agenda on daily activities and an information library.
Placebo Comparator: No-treatment status
To account for immortal time bias, each subject will be created with two clones at time zero and assigned each of the two clones to either treatment or no-treatment status, respectively. The corresponding no-treatment status is defined as subjects who have not received the digital intervention for the corresponding length of time.
Web-based multi-domain lifestyle training intervention will be conducted to promoted and focus three lifestyles: nutritional advice, exercise and cognitive training; chat communication with research team, and personalized agenda on daily activities and an information library.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Health-related quality of life (HRQL)
Time Frame: Changes from baseline to 3 month, 6 month, 9 month, and 12 month post-intervention.
Measure by EQ-5D-5L (range from -0.59 to 1.0), higher score indicates better quality of life
Changes from baseline to 3 month, 6 month, 9 month, and 12 month post-intervention.
Physical function
Time Frame: Changes from baseline to 3 month, 6 month, 9 month, and 12 month post-intervention.
Measured by Short Physical Performance Battery (range from 0 to 12), with higher score indicating better physical performance
Changes from baseline to 3 month, 6 month, 9 month, and 12 month post-intervention.
Cognitive function score
Time Frame: Changes from baseline to 3 month, 6 month, 9 month, and 12 month post-intervention.
Measured by 5-minute Montreal Cognitive Assessment (MoCA) (range from 0 to 30), A score of 26 or over is considered to be normal.
Changes from baseline to 3 month, 6 month, 9 month, and 12 month post-intervention.
Subjective Memory Score
Time Frame: Changes from baseline to 3 month, 6 month, 9 month, and 12 month post-intervention.
Measured by 7-item Memory Complaint Scale (MCS) (range from 0 to 14), lower score indicates better memory performance. No MCs (0-2), Mild MCs (3-6), Moderate MCs (7-10), Severe MCs (11-14).
Changes from baseline to 3 month, 6 month, 9 month, and 12 month post-intervention.
Loneliness score
Time Frame: Changes from baseline to 3 month, 6 month, 9 month, and 12 month post-intervention.
Measured by 3-item UCLA Loneliness Scale (range 3-9), higher score indicates greater loneliness.
Changes from baseline to 3 month, 6 month, 9 month, and 12 month post-intervention.
Depression score
Time Frame: Changes from baseline to 3 month, 6 month, 9 month, and 12 month post-intervention.
Measured by The 8-item Geriatric Depression Scale (range 0 to 8), with higher score indicating higher risk of depression
Changes from baseline to 3 month, 6 month, 9 month, and 12 month post-intervention.
Social function
Time Frame: Changes from baseline to 3 month, 6 month, 9 month, and 12 month post-intervention.
Measured by 8-item Social Connectedness Scale Revised (range 0 to 48), <22 indicates lack of social connectedness
Changes from baseline to 3 month, 6 month, 9 month, and 12 month post-intervention.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Doris Sau Fung YU, PhD, The University of Hong Kong

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 1, 2023

Primary Completion (Estimated)

August 1, 2024

Study Completion (Estimated)

August 1, 2024

Study Registration Dates

First Submitted

January 8, 2024

First Submitted That Met QC Criteria

January 8, 2024

First Posted (Actual)

January 22, 2024

Study Record Updates

Last Update Posted (Actual)

January 22, 2024

Last Update Submitted That Met QC Criteria

January 8, 2024

Last Verified

January 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • Digital Connect

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Aging Well

Clinical Trials on Digital intervention through Tablet

3
Subscribe